Publicaciones en las que colabora con Evelio J. Perea-Pérez (21)

2012

  1. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

  2. Sensibilidad in vitro a los antibióticos y serotipos más frecuentes de Streptococcus pneumoniae. Estudio multicéntrico

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 45-51

2003

  1. Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  3. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 3, pp. 892-895

  4. Segundo estudio multicéntrico de la sensibilidad in vitro a piperacilina-tazobactam

    Revista Espanola de Quimioterapia, Vol. 15, Núm. 2, pp. 169-175

2001

  1. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228

2000

  1. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

    Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564

1999

  1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359

  2. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180

  3. Estudio multicentrico de resistencias en enterococos. Papel de la teicoplanina

    Revista Espanola de Quimioterapia, Vol. 12, Núm. 3, pp. 237-243

1998

  1. ESTUDIO MULTICENTRICO NACIONAL DE LA ACTIVIDAD IN VITRO DE PIPERACILLINA-TAZOBACTAM

    Revista Espanola de Quimioterapia, Vol. 11, Núm. 2, pp. 139-146

1994

  1. VIGILANCIA DE LA ACTIVIDAD IN VITRO DE CEFUROXIMA

    Revista Espanola de Quimioterapia, Vol. 7, Núm. 4, pp. 282-285

1993

  1. RESISTENCIAS EN HAEMOPHILUS INFLUENZAE EN ESPANA. SEGUNDO ESTUDIO (1990)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 11, Núm. 1, pp. 19-28

1991

  1. Pauta: criterios actuales de comportamiento clínico frente a las infecciones

    Pharma Consult